The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g 4 Regulatory News (MAV4)

Share Price Information for Maven I&g 4 (MAV4)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 57.00
Bid: 56.00
Ask: 58.00
Change: 0.00 (0.00%)
Spread: 2.00 (3.571%)
Open: 57.00
High: 57.00
Low: 57.00
Prev. Close: 57.00
MAV4 Live PriceLast checked at -
Maven Income and Growth VCT 4 is an Investment Trust

To achieve long term capital appreciation and generate income by investing the majority of its funds in a diversified portfolio of shares and securities in smaller, unquoted UK companies and AIM/NEX quoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

8 Sep 2017 07:00

RNS Number : 1554Q
Maven Income & Growth VCT 4 PLC
08 September 2017
 

Maven Income and Growth VCT 4 PLC

 

Interim Results for the Six Months Ended 30 June 2017 (Unaudited)

 

The Directors announce the unaudited interim results for the six months ended 30 June 2017

 

Highlights

 

• NAV total return of 143.80p per share at 30 June 2017, compared to 143.40p at 31 December 2016

 

• NAV at 30 June 2017 of 96.35p per share after payment of the final dividend of 3.05p per share

 

• First interim dividend of 3.36p per share paid on 14 July 2017

 

• Second interim dividend declared of 3.70p, to be paid on 15 September 2017

 

• Three new VCT qualifying private company holdings added to the portfolio, with a further one completed post the period end

 

• Large pipeline of VCT qualifying investments, with a number in advanced process

Overview

During the reporting period, your Company has completed three new VCT qualifying investments in private companies operating across a diverse range of sectors, with another completed after the period end. The majority of the businesses in the investee portfolio have continued to trade well, with the result being a slight increase in NAV total return to 143.80p per share.

 

The Directors and the Manager recognise the importance of tax-free distributions to Shareholders and the Board was pleased to declare interim dividends totalling 7.06p per share.

 

In the first half of the financial year, Maven continued to focus on sourcing attractive qualifying investment opportunities that meet the requirements of the revised VCT legislation, as detailed in the 2016 Annual Report. Since the introduction of the new VCT rules in 2015, Maven has provided development capital to ten qualifying private companies, demonstrating its flexible approach and ability to adapt to the requirements of the revised legislation. It has, however, become apparent that new transactions are taking considerably longer to complete, due to the requirement to secure Advance Assurance tax clearance from HM Revenue & Customs (HMRC) for each new investment.

 

Given the complexity of the new rules, Maven maintains a cautious approach and continues to work closely with a specialist VCT adviser, engaged by the Company, to assist with the VCT tax clearance process, only completing investments once Advance Assurance has been secured. The investment team continues to progress all other aspects of live transactions in order to facilitate a swift completion once approval is granted. On this basis, there are a number of active new transactions which are well-progressed and it is anticipated that there will be a good rate of new investment activity through the second half of the financial year.

 

Dividends

As highlighted by the Board in the 2016 Annual Report, Shareholders should be aware that the move to support younger and earlier stage businesses may result in less predictable capital gains and income flows. As a result, compared to previous periods, there could be variation in the quantum and timing of future dividend payments. Due to a number of recent profitable realisations and in order to ensure your Company's ongoing compliance with the VCT regulations, on 15 June 2017 the Directors considered it appropriate to declare the early payment of a first interim dividend, and a second interim dividend was announced on 10 August 2017.

 

The first interim dividend in respect of the year ending 31 December 2017, of 3.36p per Ordinary Share and comprising 0.60p of revenue and 2.76p of capital, was paid on 14 July 2017 to Shareholders on the register at close of business on 23 June 2017. The second interim dividend of 3.70p per Ordinary Share, comprising all capital, will be paid on 15 September 2017 to Shareholders on the register at close of business on 18 August 2017. Since the Company's launch, and after receipt of both interim dividends, Shareholders will have received 54.51p per share in tax-free dividends. The effect of paying these dividends will be to reduce the NAV of the Company by the total cost of the distributions.

 

Decisions on future distributions will take into consideration the availability of surplus revenue, the proceeds from any further realisations and the VCT qualifying levels of the portfolio. While these two interim dividends will represent an aggregate amount in excess of any previous financial year, it is the Board's intention to maintain distributions for subsequent years at a similar level to that of the year ended 31 December 2016, although this will be dependent on realisations.

 

Portfolio Developments

The portfolio of private company holdings has generally performed well, resulting in the valuations of a number of investee companies being increased. It is reassuring to note that despite the political and economic uncertainty resulting from the recent General Election and the UK's intended exit from the European Union (EU), there is, to date, no discernible impact to report, aside from the short term benefit that a number of exporters have experienced following the devaluation of Sterling in June 2016.

 

Cursor Controls, a global leader in the design and niche manufacture of trackballs for cursor movement used in industrial applications, has performed well since Maven clients invested in July 2015. The business continues to deliver good levels of organic growth and performance was further enhanced by the acquisition, in April 2016, of Belgian based distributor of trackballs and other associated products, NSI. The acquisition formed part of Maven's investment proposal and is expected to be significantly earnings enhancing, with a number of commercial and operational synergies identified to help drive the growth and profitability of the enlarged group. The management team is encouraged by the integration process to date, with NSI trading to plan and the core Cursor business continuing to deliver organic growth.

 

Manufacturer and supplier of technical plastic components and interior parts for the global automotive industry, John McGavigan, continues to exceed expectations. The year to 31 December 2016 saw a significant increase in profitability across its operations in China and Scotland, which was achieved through top line growth enhanced by the benefits of a number of productivity improvement projects implemented earlier in the year. This strong momentum has continued in the current year, with the company continuing to grow and exceed budget. The order book remains strong, with a number of significant contracts secured in recent months, increasing the visibility of the future prospects for the business. Given the growth achieved, and forecast projections, the management team has decided to move its Chinese premises in anticipation of capacity constraints in the region, and work is progressing to advance this.

 

Maven clients invested in Attraction World, a leading provider of worldwide theme park and attraction tickets, in 2010, supporting the incumbent executive team through a management buy-out. Since investment, the company has made steady progress, and the core business continues to perform well. In March 2016, the business enhanced its operating platform through the complementary acquisition of Day Out With The Kids (www.dayoutwiththekids.co.uk), an e-commerce site that focuses on UK attraction information. The development of the new acquisition is progressing to plan and the management team believes that, over time, it will prove to be a valuable addition to the business.

 

Crawford Scientific, the UK's leading independent provider of outsourced chromatography consumable products and services to the laboratory research and testing sectors, continues to trade ahead of plan. The business leverages its world-class technical expertise to offer end-to-end solutions for users of chromatography instruments and techniques. Crawford has consistently outperformed since the initial investment by Maven clients in August 2014, including the successful acquisition and integration of analytical services company Hall Analytical Laboratories during 2015. The business continues to make good progress across all divisions and is on track to deliver further growth in the current year.

 

The UK's largest provider of promotional merchandise, SPS (EU), has achieved excellent growth under private equity ownership since Maven clients invested in February 2014. Operational improvements have enhanced profitability following the successful implementation of a new enterprise resource planning system. The complementary acquisitions of HPP and TEC, completed during the year to 31 December 2015, have been successfully integrated within the group and are both delivering a positive profit contribution. The company has invested in sales resource to help penetrate the European market, and this region is starting to contribute significantly to group performance. The balance sheet remains healthy and the business continues to reduce its core term debt.

 

DPP provides mechanical and electrical maintenance and installation services mainly to the leisure, hospitality and retail sectors in the south of England and in Wales. The company differentiates itself by operating through an employed and managed team of engineers, as opposed to engaging with a network of subcontractors. The business has made considerable progress over the past twelve months by enhancing operational procedures and reducing costs, which has led to a significant improvement in profitability. A number of new contracts were secured during the year and the outlook is positive, which is highly encouraging given the challenges experienced during 2014 when DPP lost a key customer.

 

In light of current trading, the valuations of the investments in CHS Engineering Services, Claven, Flexlife and Lambert Contracts have been protectively reduced.

 

The Manager maintains a close working relationship with investee companies operating within the oil & gas sector and it is encouraging to report that the majority of these assets are seeing early signs of improving market conditions which, after three years of steady decline, appear to have stabilised. Following extensive cost cutting, the Maven portfolio companies are operating with lean structures and have limited or no external debt. As such, they are relatively well positioned to benefit from a market recovery. The majority of Maven's investee companies in this market are focused on operational expenditure, particularly related to health and safety. Although budgets have been set conservatively, there is evidence of growing confidence, with order books and workshops recording higher activity levels. The Board will continue to monitor the performance of investee companies in this sector, maintaining a conservative approach to valuations until there is evidence of a sustained recovery. 

 

The recent new investments in private equity investment trusts and real estate investment trusts have performed well over the period, generating valuable capital growth and income through dividend payments. The Board and the Manager are encouraged by this contribution and believe that these investments will provide a steady and reliable source of income for your Company. This is particularly important in light of the restrictions introduced in the March 2016 Budget Statement, which prevent VCTs investing in traditional instruments such as treasury bills or other government securities for liquidity management purposes.

 

The Board and the Manager remain highly cognisant of the importance of maintaining an effective liquidity management policy and will continue to consider a range of other permitted income generating investment options.

 

New Investments

During the period, your Company provided development capital to three private companies operating across a range of sectors:

 

ebb3 is a technology company that develops mobile workspace solutions, addressing the need for seamless and secure access to apps, files and services on any device, in any location. The technology is specifically targeted at high-end 3D computer graphics users within the automotive (Formula 1), construction, oil & gas and education sectors, where there is a requirement for data-intensive applications that can service geographically dispersed, multi-disciplinary teams. ebb3 has high profile partnership agreements with providers such as Cisco, NetApp and NVidia, and the investment will enable the business to pursue its growth strategy in this niche part of the growing supercomputing market.

 

Horizon Cremation plans to develop and operate a portfolio of next generation crematoria across the UK, where existing facilities are either under-invested or in short supply. Horizon is seeking to build contemporary facilities that are environmentally and technologically advanced, offering enhanced professional service and care levels for families. The investment will provide capital to source and secure subsequent development sites, whilst supporting the operational expenditure and overheads of the first crematorium in North Ayrshire, Scotland, where construction commenced in May 2017.

 

ITS Technology is a leading alternative network provider that owns and maintains fibre networks, providing faster and more reliable broadband connectivity, and related services, to customers, particularly in areas that are not well serviced by the existing infrastructure. The business currently has twelve fibre broadband networks in operation, with a further five under construction. The investment will help to fund growth within the existing networks, build a stable recurring revenue base and also support expansion through the addition of new networks.

 

The following investments have been completed during the reporting period:

 

 

 

Date

 

 

Sector

Investment

cost

£'000

 

 

Website

Unlisted

ebb3 Limited

May 2017

Software &

150

www.ebb3.com

computer services

Horizon Cremation Limited

May 2017

Support services

416

horizoncremation.co.uk

ITS Technology Group Limited

June 2017

Telecommunication

398

www.itstechnologygroup.com

services

Total unlisted

964

Total investments

964

 

At the period end, the portfolio stood at 76 unlisted and quoted investments, at a total cost of £27.20 million.

 

Realisations

During the period, deferred consideration was received in respect of the exits from Lab M and Nenplas, which completed in previous periods. In addition, recovery proceeds were released for Space Student Living and Cyclotech.

 

The table below gives details of all realisations achieved, and deferred considerations received, during the reporting period:

 

 

 

 

Year first invested

 

 

 

Complete/ partial exit

Cost of shares disposed

of

£'000

Value at

31

December

2016

£'000

 

 

Sales proceeds

£'000

 

 

Realised gain/(loss)

£'000

Gain/(loss) over 31 December 2016 value

£'000

Unlisted

Cyclotech Limited

2007

Complete

-

-

49

49

49

Lab M Holdings Limited

1998

Complete

-

-

158

158

158

Nenplas Holdings Limited

2013

Complete

-

-

29

29

29

Space Student Living Limited

2011

Partial

-

67

67

67

-

Total unlisted

-

67

303

303

236

-

Total disposals

67

303

303

236

 

As at the date of this report, the Manager is engaged with several investee companies and prospective acquirers at various stages of the negotiation process, although there can be no certainty that these discussions will result in profitable sales.

 

Material Developments Since the Period End

Since 30 June 2017, one new private company asset has been added to the portfolio.

 

Contego Fraud Solutions is a provider of a complex, multi-source compliance and fraud detection software platform for public and private sector clients including property, banking and financial services companies. The application performs a vast number of screening, verification and vetting assessments including Know Your Customer and Anti-Money Laundering, to fulfil both real-time customer on-boarding and on-going monitoring of regulatory requirements. The investment will support the continued growth of the business, facilitating the hiring of additional sales resources, further product development and expansion into new markets.

 

Principal Risks and Uncertainties

The principal risks and uncertainties facing the Company were set out in full in the Strategic Report contained within the 2016 Annual Report, and are the risks associated with investment in small and medium sized unlisted and AIM/NEX quoted companies which, by their nature, carry a higher level of risk and are subject to lower liquidity than investments in large quoted companies. The valuation of investee companies may be affected by economic conditions, the credit environment and other risks including legislation, regulation, adherence to VCT qualifying rules and the effectiveness of the internal controls operated by the Company and the Manager. These risks and procedures are reviewed regularly by the Audit and Risk Committees and reported to your Board. The Board has confirmed that all tests, including the criteria for VCT qualifying status, continue to be monitored and met.

 

Share Buy-backs

Shareholders have given the Board authority to buy back shares for cancellation or to be held in treasury, subject always to such transactions being in the best interests of Shareholders. It is intended that, subject to market conditions, available liquidity and the maintenance of the Company's VCT status, shares will be bought back at prices representing a discount of up to 15% of the prevailing NAV per share. During the period under review, 233,000 shares were bought back at a total cost of £204,000.

 

Regulatory Developments

The Chancellor's March 2017 Budget Statement did not introduce any further amendments to the legislation governing VCTs, but reiterated the announcements made in the 2016 Autumn Statement. The most noteworthy of these was that the Government will no longer be initiating a review of the provision to allow replacement capital in certain new VCT transactions, suggesting that this may be reviewed at some point in the future. Whilst the Board and the Manager were disappointed by this announcement, as the ability to include replacement capital was viewed as an important capability under the new rules, it does not impact the Company's investment strategy, which has already adapted to meet the requirements of the new rules.

 

In addition, in response to the increased volume of VCT applications submitted and the resultant delays experienced in obtaining clearance for proposed investments, a consultation was launched into the options to streamline the Advance Assurance service provided by HMRC. The summary responses of this consultation were released in late March 2017 and a further detailed report and analysis is expected in due course.

 

Offers for Subscription

On 19 July 2017 the Directors of your Company, together with those of Maven Income and Growth VCT 3 PLC, announced their intention to raise up to £30 million, in aggregate, by way of Offers for Subscription of new Ordinary Shares, with over- allotment facilities of up to, in aggregate, £10 million. It is anticipated that shares will be issued in the 2017/18 and 2018/19 tax years.

 

The Board of your Company is confident that, given the strength of the current pipeline of private company introductions, the Manager will continue to be able to identify and complete VCT qualifying transactions in line with the investment strategy.

 

A Prospectus, containing full details of the Offers, is intended for publication in September 2017.

 

Dividend Investment Scheme

The Directors have also resolved to re-introduce the Dividend Investment Scheme (DIS), which was suspended on 24 August 2015 due to the restrictions imposed by the Government's summer 2015 Budget. Now that there is more clarity regarding the investment criteria that apply to VCTs, and with the Company having stated its intention to launch an Offer for Subscription, the DIS has been reinstated, as announced on 10 August 2017.

 

This means that, unless Shareholders advise otherwise, those Shareholders who had previously elected to participate in the DIS will revert to receiving new shares with effect from 15 September 2017, being the payment date of the second interim dividend. Shares issued under the DIS qualify for the VCT tax reliefs applicable for the tax year in which they are allotted. Full details of the scheme, together with a mandate form, are available from the Company's website. Shareholders who had not previously applied to participate in the DIS and who wish to do so for future dividends should ensure that a mandate form, or CREST instruction if appropriate, is submitted.

 

Outlook

The Manager is encouraged by the performance achieved during the reporting period. Notwithstanding the pressures of the uncertain economic and political backdrop following the UK's decision to leave the EU, and the more recent General Election, the portfolio of investee companies has generally continued to trade well with no discernible impact on performance as a consequence of the uncertainty. This demonstrates the strength and breadth of the underlying portfolio and its ability to continue to generate positive returns for Shareholders.

 

Whilst it is early days for a number of the new investee companies, initial indications suggest that they are performing to plan and should, over time, represent valuable additions to the portfolio. During the period Maven extended its nationwide presence through the opening of four new offices, expanding the network to ten locations across the UK. Maven's regional approach ensures that the investment team is well positioned to access potential opportunities through their local network of contacts. This geographic presence is delivering a strong pipeline of prospective new investments and, based on current momentum, it is anticipated that the rate of investment in the remainder of the financial year will be at a higher level compared to the previous year, subject to securing Advance Assurance from HMRC on a case by case basis.

 

 

On behalf of the Board

Maven Capital Partners UK LLP

Secretary

 

8 September 2017

 

 

Summary of Investment Changes

For the Six Months Ended 30 June 2017

 

Valuation

31 December 2016

£'000 %

Net investment/ (disinvestment)

£'000

Appreciation/ (depreciation)

£'000

Valuation

30 June 2017

£'000 %

Unlisted investments

Equities

10,547

32.4

204

857

11,608

36.9

Loan stock

15,701

48.2

457

(869)

15,289

48.6

26,248

80.6

661

(12)

26,897

85.5

 

AIM/NEX investments

Equities

775

2.4

-

94

869

2.8

 

Listed investments

Equities

19

0.1

-

8

27

0.1

Investment trusts

1,066

3.3

-

83

1,149

3.7

Total investments

28,108

86.4

661

173

28,942

92.1

 

Other net assets

 

4,460

 

13.6

 

(1,931)

 

-

 

2,529

 

7.9

Net assets

32,568

100.0

(1,270)

173

31,471

100.0

 

 

Investment Portfolio Summary

 

As at 30 June 2017

 

 

Investment

 

Valuation

£'000

 

Cost

£'000

 

% of total

assets

 

% of equity

held

% of equity held by other

clients¹

Unlisted

Lemac No. 1 Limited (trading as John McGavigan)

2,190

698

7.0

9.1

27.7

Torridon (Gibraltar) Limited

2,173

682

6.9

3.7

36.3

SPS (EU) Limited

1,510

790

4.8

6.6

35.9

Crawford Scientific Holdings Limited

1,276

470

4.1

7.2

41.0

Ensco 969 Limited (trading as DPP)

1,060

1,060

3.4

4.6

29.9

Glacier Energy Services Holdings Limited

957

957

3.0

3.7

23.9

Vodat Communications Group Limited

819

592

2.6

6.9

34.9

Majenta Logistics Limited

800

800

2.5

10.6

39.2

Onyx Logistics Limited

800

800

2.5

10.6

39.2

Vectis Technology Limited

800

800

2.5

10.6

39.2

CatTech International Limited

780

498

2.5

4.8

25.3

Metropol Communications Limited

730

730

2.3

10.6

39.2

JT Holdings (UK) Limited (trading as Just Trays)

687

522

2.2

5.8

24.2

Fathom Systems Group Limited

681

681

2.2

7.7

52.3

GEV Holdings Limited

672

672

2.1

4.3

31.7

Maven Capital (Marlow) Limited

650

650

2.1

-

100.0

HCS Control Systems Group Limited

604

836

1.9

6.8

29.7

Flow UK Holdings Limited

598

598

1.9

7.3

27.7

R&M Engineering Group Limited

581

774

1.8

8.7

61.9

CB Technology Group Limited

559

559

1.8

11.4

67.6

TC Communications Holdings Limited

554

777

1.8

8.1

21.9

Constant Progress Limited

500

500

1.6

9.8

40.0

Equator Capital Limited

500

500

1.6

9.8

40.0

Toward Technology Limited

500

500

1.6

9.8

40.0

RMEC Group Limited

463

463

1.5

2.9

47.2

Horizon Cremation Limited

416

416

1.3

13.9

69.8

Maven Co-invest Endeavour Limited Partnership

414

360

1.3

7.0

93.0

(invested in Global Risk Partners)²

Castlegate 737 Limited (trading as Cursor Controls)

401

299

1.3

3.0

44.5

Attraction World Holdings Limited

400

98

1.3

6.2

32.2

ITS Technology Group Limited

398

398

1.3

3.9

61.2

The GP Service (UK) Limited

398

398

1.3

4.9

27.6

Rockar 2016 Limited (trading as Rockar)

353

353

1.1

1.9

11.8

Flexlife Group Limited

352

482

1.1

1.9

12.7

QikServe Limited

348

348

1.1

3.5

16.5

Martel Instruments Holdings Limited

311

347

1.0

4.2

40.0

 

 

Investment Portfolio Summary (continued)

 

As at 30 June 2017

 

 

Investment

 

Valuation

£'000

 

Cost

£'000

 

% of total

assets

 

% of equity

held

% of equity held by other

clients¹

Unlisted (continued)

Lambert Contracts Holdings Limited

292

821

0.9

12.3

52.4

Chic Lifestyle Limited (trading as Chic Retreats)

254

254

0.8

7.6

39.3

Endura Limited2

229

229

0.7

0.7

5.2

ISN Solutions Group Limited

207

327

0.7

4.6

50.4

Whiterock Group Limited

159

159

0.5

3.5

21.5

ebb3 Limited

150

150

0.5

3.5

21.0

Growth Capital Ventures Limited

149

149

0.5

4.1

26.4

Lawrence Recycling and Waste Management Limited

109

770

0.3

8.4

53.6

Space Student Living Limited

67

-

0.2

10.6

69.4

Claven Holdings Limited

46

170

0.1

9.6

40.4

Other unlisted investments

-

1,673

-

Total unlisted

26,897

25,110

85.5

 

Quoted

Ideagen PLC

460

184

1.6

0.3

1.8

Oxford Metrics PLC (formerly OMG PLC)

136

80

0.4

0.2

-

Vectura Group PLC

125

100

0.4

-

-

Plastics Capital PLC

100

85

0.3

0.2

1.2

Angle PLC

33

27

0.1

0.1

0.4

esure Group PLC

27

-

0.1

-

-

Deltex Medical Group PLC

8

33

-

0.1

-

Work Group PLC

5

151

-

0.7

2.5

Other quoted investments

2

392

-

Total quoted

896

1,052

2.9

 

Private equity investment trusts

HgCapital Trust PLC

120

100

0.4

-

0.1

Princess Private Equity Holding Limited

120

98

0.4

-

0.1

F&C Private Equity Investment Trust PLC

119

103

0.4

0.1

0.3

Apax Global Alpha Limited

116

99

0.3

-

0.1

Standard Life Private Equity Trust PLC

55

43

0.2

-

-

Total private equity investment trusts

530

443

1.7

 

 

Investment Portfolio Summary (continued)

 

As At 30 June 2017

 

 

Investment

 

Valuation

£'000

 

Cost

£'000

 

% of total

assets

 

% of equity

held

% of equity held by other

clients¹

Real estate investment trusts

Schroder REIT Limited

110

99

0.4

-

0.2

Custodian REIT PLC

109

99

0.4

-

0.2

Target Healthcare REIT PLC

102

98

0.3

-

0.2

Standard Life Investment Property Income Trust

101

99

0.3

-

0.2

Limited

British Land Company PLC

100

99

0.3

-

-

Regional REIT Limited

97

99

0.3

-

0.2

Total real estate investment trusts

619

593

2.0

Total investments

28,942

27,198

92.1

 

¹ Other clients of Maven Capital Partners UK LLP

² These investments are managed by Penta Capital LLP of which a Director of the Company, Steven Scott, is a partner.

 

 

Income Statement

 

For the Six Months Ended 30 June 2017

Six months ended

30 June 2017

(unaudited)

Six months ended

30 June 2016

(unaudited)

Year ended

31 December 2016

(audited)

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

Gains on investments

-

173

173

-

237

237

-

1,424

1,424

Income from investments

469

-

469

420

-

420

1,057

-

1,057

Other income

5

-

5

1

-

1

4

-

4

Investment management

(85)

(339)

(424)

(89)

(354)

(443)

(215)

(862)

(1,077)

fees

Other expenses

(116)

-

(116)

(124)

-

(124)

(400)

-

(400)

Net return on ordinary

273

(166)

107

208

(117)

91

446

562

1,008

activities before taxation

 

Tax on ordinary activities

 

(23)

 

23

 

-

 

(20)

 

20

 

-

 

(85)

 

85

 

-

Return attributable to Equity Shareholders

 

250

 

(143)

 

107

 

188

 

(97)

 

91

 

361

 

647

 

1,008

 

Earnings per share (pence)

 

0.76

 

(0.44)

 

0.32

 

0.57

 

0.29

 

0.86

 

1.09

 

1.95

 

3.04

 

All gains and losses are recognised in the Income Statement.

 

All items in the above statement are derived from continuing operations. The Company has only one class of business and one reportable segment, the results of which are set out in the Income Statement and Balance Sheet. The Company derives its income from investments made in shares, securities and bank deposits.

 

There are no potentially dilutive capital instruments in issue and, therefore, no diluted returns per share figures are relevant. The basic and diluted earnings per share are therefore identical.

 

The total column of this statement is the Profit and Loss Account of the Company.

 

The accompanying Notes are an integral part of the Financial Statements.

 

 

Statement of Changes in Equity

 

For the Six Months Ended 30 June 2017

 

Share capital

£'000

Share premium account

£'000

Capital reserve realised

£'000

Capital reserve unrealised

£'000

Special distributable

reserve

£'000

Capital redemption

reserve

£'000

 

Revenue reserve

£'000

 

 

Total

£'000

At 31 December 2016

3,290

19,449

(1,571)

1,874

8,528

354

644

32,568

Net return

-

-

(13)

(130)

-

-

250

107

Dividends paid

-

-

(934)

-

-

-

(66)

(1,000)

Repurchase and cancellation of shares

(23)

-

-

-

(204)

23

-

(204)

At 30 June 2017

3,267

19,449

(2,518)

1,744

8,324

377

828

31,471

 

 

For the Six Months Ended 30 June 2016

 

 

 

 

 

Share capital

£'000

Share premium account

£'000

Capital reserve realised

£'000

Capital reserve unrealised

£'000

Special distributable

reserve

£'000

Capital redemption

reserve

£'000

 

Revenue reserve

£'000

 

 

Total

£'000

At 31 December 2015

3,354

19,449

(697)

1,401

9,096

290

983

33,876

Net return

-

-

199

(296)

-

-

188

91

Dividends paid

-

-

(517)

-

-

-

(500)

(1,017)

Repurchase and cancellation of shares

(30)

-

-

-

(266)

30

-

(266)

At 30 June 2016

3,324

19,449

(1,015)

1,105

8,830

320

671

32,684

 

 

For the Year Ended 31 December 2016

 

 

 

 

Share capital

£'000

Share premium account

£'000

Capital reserve realised

£'000

Capital reserve unrealised

£'000

Special distributable

reserve

£'000

Capital redemption

reserve

£'000

 

Revenue reserve

£'000

 

 

Total

£'000

At 31 December 2015

3,354

19,449

(697)

1,401

9,096

290

983

33,876

Net return

-

-

174

473

-

-

361

1,008

Dividends paid

-

-

(1,048)

-

-

-

(700)

(1,748)

Repurchase and cancellation of shares

(64)

-

-

-

(568)

64

-

(568)

At 31 December 2016

3,290

19,449

(1,571)

1,874

8,528

354

644

32,568

 

The accompanying Notes are an integral part of the Financial Statements.

 

 

Balance Sheet

 

As at 30 June 2017

30 June 2017 (unaudited)

£'000

30 June 2016 (unaudited)

£'000

31 December 2016

(audited)

£'000

Fixed assets

Investments at fair value through profit or loss

28,942

30,989

28,108

 

Current assets

Debtors

422

365

347

Cash

2,151

1,373

4,394

2,573

1,738

4,741

Creditors

Amounts falling due within one year

(44)

(43)

(281)

Net current assets

2,529

1,695

4,460

Net assets

31,471

32,684

32,568

 

Capital and reserves

Called up share capital

3,267

3,324

3,290

Share premium account

19,449

19,449

19,449

Capital reserve - realised

(2,518)

(1,015)

(1,571)

Capital reserve - unrealised

1,744

1,105

1,874

Special distributable reserve

8,324

8,830

8,528

Capital redemption reserve

377

320

354

Revenue reserve

828

671

644

Net assets attributable to Ordinary Shareholders

31,471

32,684

32,568

 

Net asset value per Ordinary Share (pence)

 

96.35

 

98.33

 

99.00

 

The Financial Statements were approved by the Board of Directors on 8 September 2017 and were signed on its behalf by:

 

 

 

Ian Cormack

Director

 

The accompanying Notes are an integral part of the Financial Statements.

 

 

Cash Flow Statement

 

For the Six Months Ended 30 June 2017

Six months ended

30 June 2017 (unaudited)

£'000

Six months ended

30 June 2016 (unaudited)

£'000

Year ended

31 December 2016

(audited)

£'000

Net cash flows from operating activities

(783)

(954)

(1,618)

 

Cash flows from investing activities

Investment income received

400

459

1,106

Deposit interest received

5

1

4

Purchase of investments

(964)

(4,141)

(6,441)

Sale of investments

303

6,529

12,897

Net cash flows from investing activities

(256)

2,848

7,566

 

Cash flows from financing activities

Equity dividends paid

(1,000)

(1,017)

(1,748)

Repurchase of Ordinary Shares

(204)

(266)

(568)

Net cash flows from financing activities

(1,204)

(1,283)

(2,316)

Net (decrease)/increase in cash

(2,243)

611

3,632

 

Cash at beginning of period

 

4,394

 

762

 

762

Cash at end of period

2,151

1,373

4,394

 

The accompanying Notes are an integral part of the Financial Statements.

 

 

NOTES TO THE FINANCIAL STATEMENTS

 

1. Accounting Policies

The financial information for the six months ended 30 June 2017 and the six months ended 30 June 2016 comprises non-statutory accounts within the meaning of S435 of the Companies Act 2006. The financial information contained in this report has been prepared on the basis of the accounting policies set out in the Annual Report and Financial Statements for the year ended 31 December 2016, which have been filed at Companies House and which contained an Auditor's Report which was not qualified and did not contain a statement under S498(2) or S498(3) of the Companies Act 2006.

 

2. Reserves

 

Share premium account

The share premium account represents the premium above nominal value received by the Company on issuing shares net of issue costs.

 

Capital reserves

Gains or losses on investments realised in the year that have been recognised in the Income Statement are transferred to the capital reserve realised account on disposal. Furthermore, any prior unrealised gains or losses on such investments are transferred from the capital reserve unrealised account to the capital reserve realised account on disposal.

 

Increases and decreases in the fair value of investments are recognised in the Income Statement and are then transferred to the capital reserve unrealised account. The capital reserve realised account also represents capital dividends, capital investment management fees and the tax effect of capital items.

 

Special distributable reserve

The total cost to the Company of the repurchase and cancellation of shares is represented in the special distributable reserve account.

 

Capital redemption reserve

The nominal value of shares repurchased and cancelled is represented in the capital redemption reserve.

 

Revenue reserve

The revenue reserve represents accumulated profits retained by the Company that have not been distributed to Shareholders as a dividend.

 

3. Return per Ordinary Share

Six months ended

30 June 2017

The returns per share have been based on the following figures:

Weighted average number of Ordinary Shares

32,804,662

 

Revenue return

 

£250,000

Capital return

(£143,000)

Total return

£107,000

 

 

Directors' Responsibility Statement

 

The Directors confirm that, to the best of their knowledge:

 

• the Financial Statements for the six months ended 30 June 2017 have been prepared in accordance with FRS 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland;

 

• the Interim Management Report includes a fair review of the information required by DTR 4.2.7R in relation to the indication of important events during the first six months, and of the principal risks and uncertainties facing the Company during the second six months, of the year ending 31 December 2017; and

 

• the Interim Management Report includes adequate disclosure of the information required by DTR 4.2.8R in relation to material related party transactions and any changes therein.

 

Other information

 

A full copy of the Interim Report and Financial Statements will be printed and issued to Shareholders. Copies of this announcement will be available to the public at the registered office of the Company at Kintyre House, 205 West George Street, Glasgow G2 2LW; at the office of the Manager, Maven Capital Partners UK LLP, 5th Floor, 1-2 Royal Exchange Buildings, London EC3V 3LF; and, in due course, on the Company's website at www.mavencp.com/migvct4.

 

Neither the content of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement.

 

By order of the Board

Maven Capital Partners UK LLP

Secretary

 

8 September 2017

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR EASNXEEXXEFF
Date   Source Headline
19th Apr 202412:17 pmRNSIssue of Supplementary Prospectus
5th Apr 20243:48 pmRNSIssue of Equity
27th Mar 202410:39 amRNSIssue of Equity
25th Mar 202410:14 amRNSStatement re Offer for Subscription
19th Mar 20245:03 pmRNSTransaction in Own Shares
20th Feb 20242:48 pmRNSDividend Declaration
8th Feb 202410:33 amRNSDirector/PDMR Shareholding
8th Feb 202410:10 amRNSIssue of Equity
17th Jan 202410:03 amRNSDirector/PDMR Shareholding
17th Jan 202410:02 amRNSDirector/PDMR Shareholding
17th Jan 20249:58 amRNSIssue of Equity
15th Jan 20244:28 pmRNSUnaudited Net Value Asset
15th Nov 20235:06 pmRNSTransaction in Own Shares
9th Nov 20233:53 pmRNSNet Asset Value(s)
9th Nov 20233:49 pmRNSResult of General Meeting
13th Oct 20234:56 pmRNSPublication of a Prospectus
13th Oct 202310:17 amRNSDirector/PDMR Shareholding
13th Oct 202310:15 amRNSIssue of Equity - Dividend Investment Scheme
6th Oct 20232:39 pmRNSStatement re Dividend Investment Scheme
8th Sep 20235:01 pmRNSTransaction in Own Shares-Corrective announcement
7th Sep 20233:35 pmRNSTransaction in Own Shares
30th Aug 20232:02 pmRNSHalf-year Report
17th Aug 20233:26 pmRNSStatement re NAV and Interim Dividend
12th Jul 20234:09 pmRNSHolding(s) in Company
10th Jul 20235:06 pmRNSHolding(s) in Company
2nd Jun 202310:05 amRNSDirector/PDMR Shareholding
2nd Jun 20239:43 amRNSIssue of Equity
24th May 20235:10 pmRNSTransaction in Own Shares
23rd May 202310:18 amRNSDirector/PDMR Shareholding
23rd May 202310:17 amRNSIssue of Equity - Dividend Investment Scheme
12th May 20233:38 pmRNSNet Asset Value(s) - Dividend Investment Scheme
11th May 20233:01 pmRNSResult of AGM
11th May 20232:20 pmRNSNet Asset Value(s)
27th Apr 20231:04 pmRNSIssue of Supplementary Prospectus
13th Apr 20237:00 amRNSAnnual Financial Report
5th Apr 202312:36 pmRNSDirector/PDMR Shareholding
5th Apr 202312:30 pmRNSIssue of Equity
29th Mar 20232:19 pmRNSIssue of Supplementary Prospectus
21st Mar 20234:08 pmRNSTransaction in Own Shares
3rd Mar 20239:56 amRNSIssue of Equity
21st Feb 20234:11 pmRNSUnaudited NAV and Proposed Final Dividend
21st Feb 20233:10 pmRNSUnaudited Net Asset Value, Proposed Final Dividend
16th Feb 20237:00 amRNSStatement re Offer for Subscription
8th Feb 202310:24 amRNSDirector/PDMR Shareholding
8th Feb 202310:17 amRNSDirector/PDMR Shareholding
8th Feb 20239:44 amRNSIssue of Equity
3rd Feb 20233:12 pmRNSProvisional Net Asset Value
23rd Nov 20224:53 pmRNSTransaction in Own Shares
10th Nov 20223:33 pmRNSNet Asset Value(s)
9th Nov 20223:02 pmRNSResult of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.